Silverio Tomao

Pubblicazioni

Titolo Pubblicato in Anno
RE: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition JOURNAL OF THE NATIONAL CANCER INSTITUTE 2019
Paclitaxel and Alisertib in recurrent ovarian cancer JAMA ONCOLOGY 2019
Adjuvant therapy for early uterine high-grade leiomyosarcoma JOURNAL OF CLINICAL ONCOLOGY 2019
Early clear cell “sugar” lung cancer management. A case report and a brief literature review THORACIC CANCER 2019
Circulating tumor cells in right-and left-sided colorectal cancer CANCERS 2019
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development CANCER CHEMOTHERAPY AND PHARMACOLOGY 2019
Fertility preservation and reproductive health in patients undergoing hematopoietic stem cell transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 2019
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives JOURNAL OF HEMATOLOGY & ONCOLOGY 2019
Intraperitoneal chemotherapy in advanced ovarian cancer: old and novel questions JOURNAL OF CLINICAL ONCOLOGY 2019
Combined surgery and radiotherapy as curative treatment for tracheal adenoid cystic carcinoma: A case report JOURNAL OF MEDICAL CASE REPORTS 2019
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature AGING CLINICAL AND EXPERIMENTAL RESEARCH 2018
Paclitaxel and pazopanib in ovarian cancer JAMA ONCOLOGY 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study CANCER BIOLOGY & THERAPY 2018
Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomas TRANSLATIONAL MEDICINE COMMUNICATIONS 2018
INfluenza vaccine indication during therapy with Immune checkpoint inhibitors: a transversal challenge. the INVIDIa study IMMUNOTHERAPY 2018
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study IMMUNOTHERAPY 2018
Observational study of coagulation activation in early breast cancer. development of a prognostic model based on data from the real world setting JOURNAL OF TRANSLATIONAL MEDICINE 2018
Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: case report and review of the literature ONCOLOGY LETTERS 2018
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab CANCER BIOLOGY & THERAPY 2018
Progesterone therapy in endometrial cancer AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2018

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma